What's New in Cancer Care

Women, Sex, and Cancer: We Need to Talk About It!

Saketh R. Guntupalli, MD, FACS, University of Colorado The impact of a cancer diagnosis on sexual and marital health is a topic that is...

Early Relapse in Lymphoma: What are the Implications, and What Are the Options?

Presentation by Amanda Cashen, MD, Washington University, St. Louis at ESMO22 Pennsylvania. When patients with lymphoma experience what...

What Exactly Are Antibody Drug Conjugates, and Why Are They Important in Metastatic Breast Cancer?

Presentation by Sramila Aithal, MD, Alliance Cancer Specialists at ESMO22 Pennsylvania. Chemotherapy drugs have been used for decades in...

Immunotherapy and Targeted Treatments for mNSCLC: Some Updates from ESMO 2022

Presentation by Neal Ready, MD, PhD, Duke Health at ESMO22 Pennsylvania. Treatment of patients with metastatic, non-small cell lung...

What’s New in Small-Cell Lung Cancer: A Quick Update from ESMO 2022

Paul Bunn, MD, University of Colorado, presents during the first-ever US-based ESMO Series – 2022 ESMO Colorado. At this year’s...

Updates in Oligometastatic Prostate Cancer: A Multidisciplinary Perspective

Dr. Bruno Bastos, from Miami Cancer Institute, presents during the first-ever US-based ESMO Conference – 2022 ESMO Florida. In the...

Genomic Testing in Early Breast Cancer – Who, Which Test, When

Dr. Reshma Mahtani, from Miami Cancer Institute, and Dr. Terry Mamounas from Orlando Health Cancer Institute, present during the...

Immunotherapy as an Alternative to Chemotherapy in the Elderly Lung Cancer Patient: IPSOS Trial

Dr. Solange Peters, President of the European Society for Medical Oncology, presents during the first-ever US-based ESMO Conference –...